Исследования
Образование
Решения
RU
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Türkçe
JA - 日本語
PL - Polski
RU - Русский
HE - עִברִית
AR - العربية
Войдите в систему
National Center for Cancer Immune Therapy,
Department of Oncology,
National Center for Cancer Immune Therapy, Department of Oncology
Cancer immunologist specialized in T cell biology, onco-immunology, and immunometabolism.
MERTK Acts as a Costimulatory Receptor on Human CD8 T Cells.
Cancer immunology research Sep, 2019 | Pubmed ID: 31266785
TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting.
Cancer immunology, immunotherapy : CII Feb, 2020 | Pubmed ID: 31664482
TAM Receptor Inhibition-Implications for Cancer and the Immune System.
Cancers Mar, 2021 | Pubmed ID: 33801886
University Hospital Herlev
Kasper Mølgaard*,1,
Anne Rahbech*,1,
Özcan Met1,
Inge Marie Svane1,
Per thor Straten1,3,
Claus Desler2,
Marlies J. W. Peeters1
1National Center for Cancer Immune Therapy, Department of Oncology, University Hospital Herlev,
2Department of Cellular and Molecular Medicine, Center for Healthy Aging, University of Copenhagen,
3Department of Immunology and Microbiology, Inflammation and Cancer Group, University of Copenhagen
Конфиденциальность
Условия эксплуатации
Политика
СВЯЖИТЕСЬ С НАМИ
РЕКОМЕНДОВАТЬ БИБЛИОТЕКЕ
НОВОСТИ JoVE
JoVE Journal
Подборки методов
JoVE Encyclopedia of Experiments
Архив
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
JoVE Quiz
JoVE Playlist
АВТОРЫ
Библиотекарь
Доступ
О JoVE
JoVE Sitemap
Авторские права © 2025 MyJoVE Corporation. Все права защищены